Avalo Therapeutics News

Avalo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Allostery Master Fund LP(7.6%),Allostery Investments LP(7.6%), etc.

May 13 12:44 ET

Avalo Therapeutics | 10-Q: Quarterly report

May 13 07:34 ET

Avalo Therapeutics | 8-K: Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates

May 13 07:34 ET

Avalo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Emerald Bioventures, LLC(5.6%),Timothy Opler(5.6%)

Apr 23 15:00 ET

Avalo Therapeutics | D: Filing D

Apr 9 17:02 ET

Avalo Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Deep Track Capital, LP(9.99%),Deep Track Biotechnology Master Fund, Ltd.(9.99%), etc.

Apr 5 16:04 ET

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Truex Samantha

Apr 3 16:13 ET

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Goldman Jonathan

Apr 3 16:10 ET

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director KANTOFF AARON

Apr 3 16:04 ET

Avalo Therapeutics | 10-K: Annual report

Mar 29 16:08 ET

Avalo Therapeutics | 8-K: Current report

Mar 29 16:08 ET

Avalo Therapeutics | DEFA14A: Others

Mar 28 06:29 ET

Avalo Therapeutics | 8-K: Current report

Mar 28 06:14 ET

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners III, L.P.(0.0%),VHCP Co-Investment Holdings III, LLC(0.0%), etc.

Feb 14 21:18 ET

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Great Point Partners, LLC(0.26%),Dr. Jeffrey R. Jay, M.D.(0.26%), etc.

Feb 14 17:35 ET

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Nantahala Capital Management, LLC(4.9%),Wilmot B. Harkey(4.9%), etc.

Feb 14 16:58 ET

Avalo Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(0.3%),Point72 Capital Advisors, Inc.(0.3%), etc.

Feb 14 10:08 ET

Avalo Therapeutics | 8-K: Current report

Jan 31 16:03 ET

Avalo Therapeutics | 8-K: Current report

Dec 28, 2023 00:00 ET

Avalo Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Persson Magnus

Dec 21, 2023 16:05 ET